Kiora Pharmaceuticals Inc (KPRX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $5.44M
Last updated: Nov 17, 2026 at 11:04 AM ET
Kiora Pharmaceuticals Inc (KPRX) Stock Forecast
Analysts expect Kiora Pharmaceuticals (KPRX) to earn -$1.14 per share in the fiscal year ending Dec 31, 2026. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.79.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Dec 31, 2026
- -$1.14
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$0.79
- EPS consensus
- Next report
- Mar 23, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$1.14 | -$1.14 to -$1.14 | 1 |
| Dec 31, 2027 | -$0.79 | -$0.79 to -$0.79 | 1 |
Quarterly Estimates
The EPS consensus rises from -$0.43 for the quarter ending Dec 31, 2026 to -$0.13 for the quarter ending Mar 31, 2027.
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.43 | N/A | 3 |
| Mar 31, 2027 | -$0.13 | -$0.13 to -$0.13 | 1 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 2 upward and 1 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
| Quarter ending Mar 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$2.66.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$1.14 | -$1.67 | -$1.67 | -$1.67 | -$2.66 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.79 | -$1.41 | -$1.41 | -$1.41 | -$1.97 | N/A |
| Quarter ending Mar 31, 2027 | -$0.13 | -$0.36 | -$0.36 | -$0.36 | N/A | N/A |
Frequently Asked Questions About KPRX
What is the KPRX stock forecast?
Consensus analyst estimates put Kiora Pharmaceuticals's EPS at -$1.14 for the fiscal year ending Dec 31, 2026.
What EPS do analysts expect from KPRX next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.14, with estimates from -$1.14 to -$1.14 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.79, with estimates from -$0.79 to -$0.79 from 1 analyst.
How many analysts cover KPRX?
1 analyst estimates EPS for Kiora Pharmaceuticals for the fiscal year ending Dec 31, 2026.
KPRX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors